TUB-010

N/A

Report date: 2024/10/28 14:36:16

Base Information

Drug NameTUB-010

Drug Alias NameTUB-010TEQ102TEQ-102

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 8Tubulin polymerisation inhibitors

TargetsTumor necrosis factor receptor superfamily member 8Tubulin

Therapy Area/IndicationsLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermanySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTubulis GmbH

China Registration ClassN/A

Develop Information

Active CompaniesOncoteq AG

Inactive CompaniesN/A

Active IndicationsLymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A